Immediate Impact
4 from Science/Nature 50 standout
Citing Papers
IL-17 and IL-17-producing cells in protection versus pathology
2022 Standout
Photocatalysis in the Life Science Industry
2021 Standout
Works of Filiz Şen being referenced
Selinexor, a First-in-Class XPO1 Inhibitor, Is Efficacious and Tolerable in Patients with Myelodysplastic Syndromes Refractory to Hypomethylating Agents
2018
Th17 and non-Th17 interleukin-17-expressing cells in chronic lymphocytic leukemia: delineation, distribution, and clinical relevance
2011
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Filiz Şen | 273 | 114 | 162 | 207 | 42 | 609 | |
| Dimitra Anagnostou | 300 | 176 | 247 | 162 | 39 | 678 | |
| Flora N. Kontopidou | 422 | 80 | 251 | 213 | 36 | 607 | |
| Andreas Himmelmann | 262 | 73 | 155 | 182 | 27 | 616 | |
| Giovanna Motta | 196 | 100 | 82 | 215 | 43 | 584 | |
| Pierre Brousset | 312 | 130 | 84 | 294 | 22 | 578 | |
| Minoru Kojima | 342 | 102 | 173 | 309 | 41 | 586 | |
| Ni‐Chun Tsai | 315 | 236 | 99 | 376 | 47 | 691 | |
| Nazan Özsan | 373 | 39 | 98 | 208 | 42 | 621 | |
| Luigi Salvagno | 248 | 120 | 72 | 265 | 44 | 606 | |
| Christopher McNamara | 313 | 61 | 128 | 217 | 36 | 705 |
All Works
Login with ORCID to disown or claim papers
Loading papers...